Enterprise Value to EBITDA Multiple ratio Analysis of Heron Therapeuti - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-1.27
Period Ending - Dec-22
Very Poor EV to EBITDA
-2.73
Growth
53.44 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-7.88
EV to EBITDA Analysis of Heron Therapeuti
| EV to EBITDA Ratio of HRTX rose handsomely by 53.44 % this year. |
| EV to EBITDA Ratio with value of -0.878 was highest in Year Dec-20 in last Five Years. |
| EV to EBITDA Ratio with value of -2.73 was lowest in Year Dec-22 in last Five Years. |
| Latest EV to EBITDA Ratio with value of -1.27 is Greater than Average EV to EBITDA of -1.52 in last five years. |
Other EV to EBITDA Related Info of HRTX that may interest you.
Heron Therapeuti Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| HRTX | 3.2 | 3.22 | 0.621 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..
EV to EBITDA Related Ratios
| EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Enterprise Value to EBITDA Multiple of Heron Therapeuti
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| EV to EBITDA | -1.27 | -2.73 | -1.72 | -0.878 | -0.981 | -1.18 | -0.297 |
| Change | 53.44 % | -58.98 % | -95.87 % | 10.47 % | 17.24 % | -298.97 % | 68.73 % |
FY Chart of Enterprise Value to EBITDA Multiple of Heron Therapeuti
Note : All Data Generated at the End of Trading Hours (EOD Data)